SCHEMBL11370239

SCHEMBL11370239

CC(Sc1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.50
DAO P14920 2/20 0.50
KMT2A Q03164 1/20 0.50
LMNA P02545 2/20 0.46
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PKM P14618 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
TAAR1 Q96RJ0 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 1/20 0.39
MGLL Q99685 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MPO P05164 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2C P18825 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10234307 0.91 SLC6A4 (0.47) L3MBTL1DAOKMT2ALMNAKDM4E
SCHEMBL29700321 0.87 L3MBTL1 (0.50) L3MBTL1DAOKMT2ALMNAALDH1A1
SCHEMBL1709986 0.87 L3MBTL1 (0.50) L3MBTL1DAOKMT2ALMNAALDH1A1
SCHEMBL10234305 0.85 DAO (0.51) L3MBTL1DAOKMT2ALMNAKDM4E
SCHEMBL13146781 0.82 DAO (0.42) L3MBTL1DAOKMT2ALMNAALDH1A1
SCHEMBL4302752 0.80 DAO (0.44) L3MBTL1DAOKMT2ALMNAKDM4E
SCHEMBL11205708 0.80 DAO (0.48) L3MBTL1DAOLMNAKDM4EALDH1A1
SCHEMBL10716957 0.80 ALDH1A1 (0.45) L3MBTL1DAOKMT2ALMNAKDM4E
SCHEMBL11205710 0.80 ALDH1A1 (0.47) L3MBTL1DAOKMT2ALMNAKDM4E
SCHEMBL9957227 0.76 MAPT (0.48) L3MBTL1DAOKMT2ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370751-B2 Sulfonium salt, heat- or photo-acid generator, heat- or photo-curable composition, and cured product thereof SAN APRO LTD. (JP) 2022-06-28 US disclosed
CN-114401975-A Novel onium salt and photoacid generator 三亚普罗股份有限公司 2022-04-26 CN disclosed
CN-111093963-B Formed body 株式会社大赛璐 2022-02-25 CN disclosed
US-10953393-B2 Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations THE UNIVERSITY OF CHICAGO (US) 2021-03-23 US disclosed
CN-111093963-A Formed body 株式会社大赛璐 2020-05-01 CN disclosed
US-20190284134-A1 SULFONIUM SALT, HEAT- OR PHOTO-ACID GENERATOR, HEAT- OR PHOTO-CURABLE COMPOSITION, AND CURED PRODUCT THEREOF SAN APRO LTD. (JP) 2019-09-19 US disclosed
US-9776958-B2 Sulfonate-based compound and method for preparing same LG CHEM, LTD. (KR) 2017-10-03 US disclosed
US-20170210707-A1 SULFONATE-BASED COMPOUND AND METHOD FOR PREPARING SAME LG CHEM, LTD. (KR) 2017-07-27 US disclosed
US-9416080-B2 Catalytic C—H bond activation GEORGETOWN UNIVERSITY (US) 2016-08-16 US disclosed
US-9416080-B2 Catalytic C—H bond activation GEORGETOWN UNIVERSITY (US) 2016-08-16 US disclosed
US-8057868-B2 Composition for forming a liquid crystal alignment film, and liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2011-11-15 US disclosed
US-20110007254-A1 COMPOSITION FOR FORMING A LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2011-01-13 US disclosed
EP-2264143-A2 Anthrax carbohydrates, synthesis and uses thereof University Of Georgia Research Foundation, Inc. (US) 2010-12-22 EP disclosed
US-7638546-B1 Imidazolyl derivatives IPSEN PHARMA S.A.S. (FR) 2009-12-29 US disclosed
US-7566734-B2 Imidazolyl derivatives SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) 2009-07-28 US disclosed
US-20070299073-A1 Imidazolyl derivatives IPSEN PHARMA S.A.S. (FR) 2007-12-27 US disclosed
US-7238695-B2 Imidazolyl derivatives SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, SAS (FR) 2007-07-03 US disclosed
US-20070032653-A1 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) 2007-02-08 US disclosed
US-4267375-A REFLUXING THIOPHENOL IN BENZENE USING ZINC CHLORIDE AS CATALYST WITH PHENYL-/-OR 2- HYDROXYPHENETHYL SULFIDE S.A. TEXACO BELGIUM N.V. (BE) 1981-05-12 US disclosed
EP-0021637-A1 Amidothiol derivatives NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1981-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190284134-A1 SULFONIUM SALT, HEAT- OR PHOTO-ACID GENERATOR, HEAT- OR PHOTO-CURABLE COMPOSITION, AND CURED PRODUCT THEREOF TST, MPST, ASIC1 L3MBTL1 3820/4885DAO 2394/4885KMT2A 3621/4885
US-11370751-B2 Sulfonium salt, heat- or photo-acid generator, heat- or photo-curable composition, and cured product thereof TST, MPST, ASIC1 L3MBTL1 3820/4885DAO 2394/4885KMT2A 3621/4885
US-20170210707-A1 SULFONATE-BASED COMPOUND AND METHOD FOR PREPARING SAME STS, TST, MPST L3MBTL1 4822/4885DAO 839/4885KMT2A 1179/4885
US-10953393-B2 Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations SBK1, SIK1, SIK2 L3MBTL1 3024/4885DAO 774/4885KMT2A 1351/4885
US-20070299073-A1 Imidazolyl derivatives SSTR5, SSTR3, SSTR2 L3MBTL1 4509/4885DAO 1502/4885KMT2A 3454/4885
US-20070032653-A1 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. GHSR, IGF1R, GIPR L3MBTL1 2514/4885DAO 2143/4885KMT2A 2496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.